CareDx to Participate in Upcoming Investor Conferences
01 Junho 2023 - 8:00AM
Business Wire
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine
company focused on the discovery, development, and
commercialization of clinically differentiated, high-value
healthcare solutions for transplant patients and caregivers – today
announced that the Company will participate in two upcoming
investor conferences.
CareDx’s management is scheduled to present at the Jefferies
Global Healthcare Conference on Thursday, June 8, 2023, at 8:00 AM
PT / 11:00 AM ET. To listen to the webcast, please visit the Events
& Presentations section of CareDx’s Investor Relations website
at: investors.caredxinc.com.
CareDx’s management will also be presenting at the Goldman Sachs
44th Annual Global Healthcare Conference on Tuesday, June 13th,
2023, at 4:40 PM PT / 7:40 PM ET. To listen to the webcast, please
visit the Events & Presentations section of CareDx’s Investor
Relations website at: investors.caredxinc.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a
leading precision medicine solutions company focused on the
discovery, development, and commercialization of clinically
differentiated, high-value healthcare solutions for transplant
patients and caregivers. CareDx offers testing services, products,
and digital healthcare solutions along the pre- and post-transplant
patient journey and is the leading provider of genomics-based
information for transplant patients. For more information, please
visit: www.CareDx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230601005225/en/
CareDx, Inc.
Media Relations Anna Czene 818-731-2203 aczene@caredx.com
Investor Relations Greg Chodaczek Investor@caredx.com
CareDx (NASDAQ:CDNA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
CareDx (NASDAQ:CDNA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024